Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers

Home › Targets › APLNR

APLNR (1 companies · 1 programs)

Companies with an active program directed at APLNR.

Tectonic Therapeutic, Inc. TECX

TX2100 — Hereditary Hemorrhagic Telangiectasia Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.